Verve Puts Digital-First Quality At The Heart Of Its QC Lab

Verve Therapeutics transformed its quality control approach by moving from external testing to an in-house, paperless lab designed for speed and scalability. Facing the challenge of GMP compliance and complex RNA technologies, the team adopted a cloud-based LIMS to unify QA and QC processes, reduce manual errors, and streamline operations. This shift enabled faster turnaround times, improved right-first-time performance, and closer collaboration with manufacturing partners. By leveraging automation, integrated compliance tools, and real-time data visibility, Verve is now positioned to scale efficiently as clinical trials expand.
Discover how a cloud-first strategy and intuitive technology helped Verve optimize lab productivity and prepare for future growth.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.